Startup News: Three cutting-edge companies file for IPO
Three high-profile startups have filed paperwork in recent weeks for initial public offerings.
rapportrx.comHealthcare / Healthcare softwareFounded: 2022Funding to Date: $250.18MM
Rapport Therapeutics is dedicated to crafting precision medicines tailored to the complexity of the human brain, marking a significant stride in the field of neuro medicines. Emphasizing a scientific partnership approach, they deliver revolutionary, relentless, and precise treatments. Their mission is to address neurological complexities with unmatched accuracy, leveraging cutting-edge research and development to create therapies that accurately match the nuanced needs of individuals.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
08/07/2023 | Series B | $150MM | $xx.xx | $409.19MM | Arch Venture Partners, Cormorant Asset Management, Fidelity Management & Research Company, Goldman Sachs Asset Management, Johnson & Johnson Innovation, Logos Capital, Perceptive Advisors, Sofinnova Investments, Surveyor Capital, Third Rock Ventures | |
Price per Share
$xx.xx
Shares Outstanding
89,431,040
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Arch Venture Partners, Cormorant Asset Management, Fidelity Management & Research Company, Goldman Sachs Asset Management, Johnson & Johnson Innovation, Logos Capital, Perceptive Advisors, Sofinnova Investments, Surveyor Capital, Third Rock Ventures
|
||||||
03/07/2023 | Series A | $100.18MM | $xx.xx | $200.36MM | Arch Venture Partners, Johnson & Johnson Innovation, Third Rock Ventures | |
Price per Share
$xx.xx
Shares Outstanding
100,182,354
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Arch Venture Partners, Johnson & Johnson Innovation, Third Rock Ventures
|
Three high-profile startups have filed paperwork in recent weeks for initial public offerings.